Commercial Services Healthcare Sector

IRADIMED

Market Cap: US$677.6m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

RxSight

Market Cap: US$675.4m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

Nika Pharmaceuticals

Market Cap: US$672.8m

A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.

Day One Biopharmaceuticals

Market Cap: US$667.0m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Savara

Market Cap: US$660.5m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Trevi Therapeutics

Market Cap: US$658.3m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

CeriBell

Market Cap: US$657.1m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

Immatics

Market Cap: US$656.4m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

Curaleaf Holdings

Market Cap: CA$908.8m

Produces and distributes cannabis products in the United States and internationally.

Vir Biotechnology

Market Cap: US$653.9m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

Fulgent Genetics

Market Cap: US$646.0m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Simulations Plus

Market Cap: US$645.3m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Anavex Life Sciences

Market Cap: US$642.9m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Evolus

Market Cap: US$642.2m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Iovance Biotherapeutics

Market Cap: US$637.8m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Taysha Gene Therapies

Market Cap: US$629.0m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

Mesa Laboratories

Market Cap: US$626.6m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Delcath Systems

Market Cap: US$625.8m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

AbCellera Biologics

Market Cap: US$623.8m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

AnaptysBio

Market Cap: US$619.9m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Sionna Therapeutics

Market Cap: US$617.7m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Arbutus Biopharma

Market Cap: US$614.8m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Dianthus Therapeutics

Market Cap: US$614.6m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Maravai LifeSciences Holdings

Market Cap: US$611.2m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

KalVista Pharmaceuticals

Market Cap: US$608.5m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

PolyNovo

Market Cap: AU$943.0m

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

Avanos Medical

Market Cap: US$605.8m

A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Cogent Biosciences

Market Cap: US$605.0m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Akso Health Group

Market Cap: US$596.1m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Tian'an Technology Group

Market Cap: US$591.7m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

Integral Diagnostics

Market Cap: AU$915.7m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

NeuroPace

Market Cap: US$590.0m

Operates as a medical device company in the United States.

Bicycle Therapeutics

Market Cap: US$589.4m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Xencor

Market Cap: US$579.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Keros Therapeutics

Market Cap: US$574.3m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Mind Medicine (MindMed)

Market Cap: US$574.2m

A clinical stage biopharmaceutical company, develops novel products to treat brain health disorders.